This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Type of economic evaluation
Cost-effectiveness analysis, cost-utility analysis
Study objective
The objective was to examine the cost-effectiveness of partial-versus whole-breast radiation therapy for postmenopausal women with oestrogen-receptor positive, early-stage breast cancer, who were receiving tamoxifen without chemotherapy.
Interventions
The two strategies were partial-and whole-breast irradiation. Two partial irradiation options were considered: external beam and MammoSite.
Location/setting
USA/out-patient.
Methods

Analytical approach:
The analysis was based on a Markov model that simulated the management of disease over 15 years. The authors stated that a societal perspective was adopted.
Effectiveness data:
The clinical evidence was derived from published studies, but the method used to identify them was not reported. Partial irradiation efficacy and the patterns of recurrence were from a single-arm, phase I and II trial. No information on the design and other characteristics of the other sources was given. The primary endpoints were the rates of recurrence with partial-breast irradiation.
Monetary benefit and utility valuations:
The utility values were derived from a published study (that used the standard gamble method) and authors' opinions, based on other studies.
Measure of benefit:
Quality-adjusted life-years (QALYs) and life-years (LYs) were the summary benefit measures and were discounted at an annual rate of 3%.
